US – Utah: The House amended and passed Senate Bill (SB) 195, so the Senate must now consider amendments made to the bill since it passed SB 195 in February. Among other things, the bill would add acute pain that is expected to last more than two weeks as a qualifying condition for medical cannabis and would impose certain marketing and advertising » Continue Reading. ...
LATEST ALERTS
View all Read our latest free content
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
Your display name will appear here.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.